Talkiatry Partners With NYCBS to Embed Psychiatric Care in Oncology via Talkiatry Connect

New updates have been reported about Talkiatry.

Talkiatry has entered a strategic partnership with New York Cancer & Blood Specialists (NYCBS) to integrate its in-network psychiatric services directly into oncology care through the Talkiatry Connect platform. Under the agreement, NYCBS clinicians can identify cancer patients needing behavioral health support, trigger referrals from within their cloud-based EMR, and monitor key milestones such as referral receipt, assessments, and initial visits.

Talkiatry Connect functions as a provider-facing, technology overlay that uses existing chart data, including diagnoses and insurance, to streamline referral decisions and reduce administrative friction for busy oncology teams. For Talkiatry, NYCBS serves as an early adopter and proof point for scaling this clinician-friendly, AI-enabled coordination model across specialty practices that require tightly integrated mental health support.

The partnership is designed to address significant unmet behavioral health needs among cancer patients, as data cited by Talkiatry show that more than 40% experience worsening mental health during treatment, while only about half receive care. By embedding psychiatry into oncology workflows and sharing high-level care-plan summaries back to referring physicians, Talkiatry aims to improve continuity, outcomes, and overall patient experience without overexposing sensitive clinical details.

Talkiatry’s Chief Medical Officer and Co-Founder, Dr. Georgia Gaveras, positioned the collaboration as a template for modern specialty care that marries clinical rigor with privacy-aware information sharing between psychiatry and oncology. NYCBS leadership likewise emphasized that integrating Talkiatry’s services enhances survivorship and emotional support while aligning with existing clinical operations, which may accelerate adoption and minimize incremental overhead.

Strategically, this move reinforces Talkiatry’s role as a preferred psychiatry partner for health systems and specialty groups, extending its footprint beyond traditional primary-care and payer channels into high-acuity oncology settings. The company, which employs more than 800 full-time psychiatrists and has delivered over 3 million patient visits, is leveraging its proprietary AI-powered infrastructure and Talkiatry Connect to deepen B2B relationships that can drive referral volumes and recurring revenue from enterprise clients.

For executives assessing Talkiatry’s trajectory, the NYCBS deployment highlights the firm’s focus on scalable integration with existing EMRs, cross-specialty collaboration, and value creation via improved outcomes and operational efficiency for partner providers. If replicated with additional oncology networks and other specialties where behavioral health is a critical comorbidity, this model could become a meaningful growth engine, strengthen Talkiatry’s competitive moat in tech-enabled psychiatric care, and enhance its attractiveness to payers and health systems seeking integrated, whole-person solutions.